Order Article Reprints

Matsumoto H, Igarashi C, Tachibana T, Hihara F, Waki A, Zhang M-R, Yoshida S, Naito K, Kurihara H, Ueno M, et al. Characterization and Stabilization of a New ⁶⁴Cu-Labeled Anti-EGFR Antibody NCAB001 for the Early Detection of Pancreatic Cancer with Positron Emission Tomography. Pharmaceutics. 2022; 14(1):67. https://doi.org/10.3390/pharmaceutics14010067

Matsumoto, Hiroki, Chika Igarashi, Tomoko Tachibana, Fukiko Hihara, Atsuo Waki, Ming-Rong Zhang, Sei Yoshida, Kenichiro Naito, Hiroaki Kurihara, Makoto Ueno, and et al. 2022. "Characterization and Stabilization of a New ⁶⁴Cu-Labeled Anti-EGFR Antibody NCAB001 for the Early Detection of Pancreatic Cancer with Positron Emission Tomography" Pharmaceutics 14, no. 1: 67. https://doi.org/10.3390/pharmaceutics14010067

Matsumoto, H., Igarashi, C., Tachibana, T., Hihara, F., Waki, A., Zhang, M.-R., Yoshida, S., Naito, K., Kurihara, H., Ueno, M., Ito, K., Higashi, T., & Yoshii, Y. (2022). Characterization and Stabilization of a New ⁶⁴Cu-Labeled Anti-EGFR Antibody NCAB001 for the Early Detection of Pancreatic Cancer with Positron Emission Tomography. Pharmaceutics, 14(1), 67. https://doi.org/10.3390/pharmaceutics14010067